Relative blood-brain barrier permeabilities of the cholecystokinin receptor antagonists devazepide and A-65186 in rats

Journal of Pharmacy and Pharmacology

Volumn 51, Issue 8, 1999, Pages 917-920

  Woltman, Todd A ^b   Hulce, Martin ^a   Reidelberger, Roger D ^b  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 14; CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; DEVAZEPIDE; IODOPHENAZONE; MANNITOL; N (3 QUINOLYLCARBONYL) DEXTRO GLUTAMIC ACID ALPHA DIPENTYLAMIDE; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BOLUS INJECTION; BRAIN; CAROTID ARTERY; CONTROLLED STUDY; INTRAARTERIAL DRUG ADMINISTRATION; MALE; NONHUMAN; PERMEABILITY; RAT; SATIETY;

ANESTHESIA; ANIMALS; ANTIPYRINE; ANTIVIRAL AGENTS; BLOOD-BRAIN BARRIER; CEREBELLUM; DEVAZEPIDE; DIURETICS, OSMOTIC; HORMONE ANTAGONISTS; MALE; MANNITOL; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CHOLECYSTOKININ;

EID: 0032861788     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357991773348     Document Type: Article

References (14)

1. Baldwin, B. A., de la Riva, C., Gerskowitch, V. P. (1994) Effect of a novel CCK-A receptor antagonist (2-NAP) on the reduction in food intake produced by CCK in pigs. Physiol. Behav. 55: 175-179
2. Brenner, L., Ritter, R. C. (1995) Peptide cholecystokinin receptor antagonist increases food intake in rats. Appetite 24: 1-9
3. Castellanos, D. A., Kerwin, J. F., Reidelberger, R. D. (1995) Effects of peripheral CCKA receptor blockade on food intake in freely feeding rats. Obes. Res. 3: 377S
4. Ebenezer, I. S., Baldwin, B. A. (1995) 2-Naphthalenesulphanyl-L-aspartyl-2-(phenethyl) amide (2-NAP) and food intake in rats: evidence that endogenous peripheral CCK does not play a major role as a satiety factor. Br. J. Pharmacol. 116: 2371-2374
5. Ebenezer, I. S., Parrott, R. F. (1993) A70104 and food intake in pigs: implication for the CCK "satiety" hypothesis. Neuroreport 4: 495-498
6. Hulce, M., Malone, J. A., Reidelberger, R. D. (1998) Synthesis of radiolabelled R-glutamic acid-derived CCK antagonists. Proc. Southwest Rocky Mt. Div. Am. Assoc. Adv. Sci. 38: 47-48
7. Hull, R. A. D., Shankley, N. P., Harper, E. A., Gerskowitch, V. P., Black, J. W. (1993) 2-Naphthalenesulphonyl L-aspartyl-(2-phenethyl)amide (2-NAP) - a selective cholecystokinin CCK-A receptor antagonist. Br. J. Pharmacol. 108: 734-740
8. Kerwin, J. F., Nadzan, A. M., Kopecka, H., Lin, C. W., Miller, T., Witte, D., Burt, S. (1989) Hybrid cholecystokinin (CCK) antagonists: new implications in the design and modification of CCK antagonists. J. Med. Chem. 32: 739-742
9. Lignon, M.-F., Galas, M.-C., Rodriguez, M., Laur, J., Aumelas, A., Martinez, J. (1987) A synthetic peptide derivative that is a cholecystokinin receptor antagonist. J. Biol. Chem. 262: 7226-7231
10. Oldendorf, W. H. (1970) Measurement of brain uptake of radiolabeled substances using a tritiated water internal standard. Brain Res. 24: 372-376
11. Oldendorf, W. H. (1971) Brain uptake of radiolabelled amino acids, amines, and hexoses after arterial injection. Am. J. Physiol. 221: 1629-1639
12. Pullen, R. G. L., Hodgson, O. J. (1987) Penetration of diazepam and the non-peptide CCK antagonist, L-364,718, into rat brain. J. Pharm. Pharmacol. 39: 863-864
13. Reidelberger, R. D. (1994) Cholecystokinin and control of food intake. J. Nutr. 124: 1327S-1333S
14. 14C]antipyrine. Am. J. Physiol. 234: H59-H66